Development of Products. 4.1 During the Research Term, Orasense will diligently pursue the research and development of the Elan Intellectual Property, Isis Intellectual Property and Orasense Technology in accordance with the Research and Development Program. The objectives of this initial phase of the Research and Development Program will be (a) to develop the Oral Platform, and (b) to develop the Development Product.
Appears in 4 contracts
Samples: License Agreement (Isis Pharmaceuticals Inc), License Agreement (Isis Pharmaceuticals Inc), License Agreement (Isis Pharmaceuticals Inc)
